Choledocholithiasis is a common biliary tract disease that causes numerous complications that can seriously influence the quality of life of patients. 1 The diagnosis of choledocholithiasis is made on the basis of signs and symptoms, results of liver function test for cholestasis, and imaging findings. In patients with suspected choledocholithiasis, endoscopic retrograde cholangiopancreatography (ERCP) has been the gold standard for the diagnosis and treatment of choledocholithiasis in the past decades. The problem of ERCP is that it is a potentially invasive procedure with several complications such as post-ERCP pancreatitis, cholangitis, bleeding, and bowel perforation. 2 Therefore, confirming the presence of choledocholithiasis before performing ERCP is frequently desirable. The reason this is important is that the risk-producing problems related to an unnecessary diagnostic ERCP increase if the patient does not have stones, while ERCP is beneficial for patients with bile duct stones. However, consensus about the optimal noninvasive diagnostic method for patients with suspected choledocholithiasis is lacking. In this issue of Clinical Endoscopy, Makmun et al. 3 conducted a retrospective study to compare sensitivity and specificity among magnetic resonance cholangiopancreatography (MRCP), endoscopic ultrasonography (EUS), and ERCP for diagnosing choledocholithiasis. They came to the conclusion that EUS had better ability than MRCP to diagnose patients with true-positive and true-negative results for choledocholithiasis (sensitivity, 96% vs. 81% and specificity, 57% vs. 40%). The positive predictive value (PPV) and negative predictive value (NPV) of EUS were also greater than those of MRCP (PPV, 85% vs. 74% and NPV, 80% vs. 50%). Several studies that compared EUS to MRCP showed both high diagnostic performance for choledocholithiasis, 4 while a recent systematic review that included eight randomized trials demonstrated a slightly higher overall accuracy for EUS than for MRCP. 5 This study also reported that EUS was superior to MRCP for detecting choledocholithiasis, which was confirmed using ERCP. However, I have a concern about the results of this study because the specificities of EUS and MRCP were much lower than those reported in previous studies. The authors did not explain clearly why the specificities of the two methods were low in this study. The most recent systematic review that included eight randomized, prospective, blinded trials revealed that the mean sensitivities of EUS and MRCP for detection of choledocholithiasis were 93.7% and 83.5%, respectively, and their specificities were 88.5% and 91.5%, respectively. 5 In this study, a lower specificity means a high number of false-positive cases for both EUS and MRCP, which indicates that the ability of the examiner to diagnose choledocholithiasis by using the two modalities is not optimized and needs to be developed. A thickened common
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To summarize, for patients with a high risk of choledocholithiasis (as determined by clinical presentation and noninvasive imaging), proceeding directly to ERCP is the best approach. 12 For patients at low-to-moderate risk of choledocholithiasis, performing EUS or MRCP first before ERCP can prevent unnecessary ERCP. 13 Owing to apparent pros and cons between these two modalities, the choice should be based on local availability and operator expertise. Further studies are needed to clarify the differences, which should include not only diagnostic performance but also the different sizes and types of stones, medical cost, and the potential for technical development, between EUS and MRCP for the diagnosis of choledocholithiasis. In my opinion, the best plan for investigating suspected common bile duct stones is to obtain an MRCP image first for patients without any contraindication. If the findings are negative but the clinical situation suggest otherwise, EUS should be performed to identify small stones or sludge that might have been missed by MRCP.
